Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q3 2020 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2020-10-27

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Oct 27, 2020

Total Value: $209M (100.0% shares, 0.0% debt)

Holdings (5)

PCVX VAXCYTE INC 44.5%

Value $93.2M Shares 1,887,478 Est. Cost $32.16 Unrealized +23.8%

PHAT PHATHOM PHARMACEUTICALS INC 36.2%

Value $75.83M Shares 2,067,861 Est. Cost $25.13 Unrealized +37.8%

— MERUS N V 9.2%

Value $19.2M Shares 1,600,000 Est. Cost $14.08 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 8.3%

Value $17.28M Shares 1,501,716 Est. Cost $11.51 Unrealized —

— OBSEVA SA 1.9%

Value $3.893M Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PCVX	VAXCYTE INC	1,887,478	$93.2M	44.5%	$32.16	+23.8%	COM	92243G108
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$75.83M	36.2%	$25.13	+37.8%	COM	71722W107
—	MERUS N V	1,600,000	$19.2M	9.2%	$14.08	—	COM	N5749R100
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$17.28M	8.3%	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$3.893M	1.9%	$3.82	—	COM	H5861P103